Viewing Study NCT02829892


Ignite Creation Date: 2025-12-24 @ 3:15 PM
Ignite Modification Date: 2026-02-22 @ 7:02 AM
Study NCT ID: NCT02829892
Status: COMPLETED
Last Update Posted: 2016-07-12
First Post: 2016-07-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Using Environmental Light Therapy to Improve Sleep and Neuropsychiatric Symptoms in Dementia
Sponsor: Centre Hospitalier Universitaire de Nice
Organization:

Study Overview

Official Title: Using Environmental Light Therapy to Improve Sleep and Neuropsychiatric Symptoms in Dementia
Status: COMPLETED
Status Verified Date: 2016-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SOLEIL SOMMEIL
Brief Summary: Alzheimer's disease and related syndromes (AD) is a disease affecting memory but also the relationship with the environment and empower people. Patients with AD present in 90% of cases of behavioral disorders and of these behavioral disorders include agitation, apathy but also sleep disorders by circadian rhythm impairment.. No study has shown proven efficacy on the behavior of patients with AD. The main objective of the study was to assess the influence of environmental light nighttime sleep of residents.
Detailed Description: Alzheimer's disease and related syndromes (AD) is a disease affecting memory but also the relationship with the environment and empower people. Patients with AD present in 90% of cases of behavioral disorders and of these behavioral disorders include agitation, apathy but also sleep disorders by circadian rhythm impairment. In 2014, the Cochrane published a systematic review of the literature over the last 20 years concerning the use of light therapy in patients with a AD. No study has shown proven efficacy on the behavior of patients with AD. The main objective of the study was to assess the influence of environmental light therapy (from 5 a.m to 10 p.m) on nighttime sleep of residents. Secondary objectives were the study of sleep time on the day, anxiety by the COVI scale and behavioral disorders by the NPI scale.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: